We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,265.00
Bid: 2,255.00
Ask: 2,270.00
Change: 10.00 (0.44%)
Spread: 15.00 (0.665%)
Open: 2,255.00
High: 2,290.00
Low: 2,240.00
Prev. Close: 2,255.00
MGNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Voting Update

4 Sep 2023 12:51

RNS Number : 3096L
Morgan Sindall Group PLC
04 September 2023
 

Morgan Sindall Group plc

Legal Entity Identifier (LEI) number: 2138008339ULDGZRB345

 

4 September 2023

Morgan Sindall Group plc ("the Company")

 

Update on response to 2023 AGM voting outcome

 

At our Annual General Meeting ('AGM') held on 4 May 2023, resolution 3 (Approval of the Directors' Remuneration Policy) was supported by a large majority of shareholders but received less than 80% support overall.

 

In advance of the 2023 AGM, the Remuneration Committee (the 'Committee') undertook a detailed engagement with the Company's largest shareholders in relation to the remuneration proposals, and had amended the final Remuneration Policy design in response to feedback received. Following the 2023 AGM, the Committee reached out to the Company's largest shareholders to continue the dialogue and listen to their views - and in particular to understand why those who either abstained or voted against the Directors' Remuneration Policy ('the 'Policy') had done so.

 

The Committee received responses from eight investors, the majority of whom reconfirmed support for the Policy and the management team. 

 

One shareholder raised the annual bonus deferral requirement and 2nd-year phasing down of the post-employment shareholding requirement as their reason for not supporting the resolution. In both cases the Committee is comfortable that its current approach supports appropriate alignment of executive and shareholder interests. In respect of the annual bonus deferral requirement, the Committee also considers this requirement appropriate given the current shareholdings of incumbent Executive Directors. However, the Committee will reconsider both of these Policy design features as part of the next Policy review.

 

The Committee also received feedback from two shareholders that their voting had reflected the 'against' recommendation from one of the major proxy voting agencies, which itself was primarily a result of the simultaneous increases to the Policy headroom available under the annual bonus and LTIP schemes. On this matter, the Committee maintains its view that the Policy should be sufficiently flexible to last for a full triennial review period rather than needing to revert to shareholders to seek incremental changes, and reiterates its commitment to write out to major shareholders in advance of using the increased maximum opportunities under either of the variable incentives.

 

Another shareholder requested that the Committee provide a full explanation in its Remuneration Report of the rationale for the adoption of any increase to the executive directors' incentive opportunities in future years, particularly in relation to the achievement of key strategic objectives, and this feedback is consistent with the current thinking of the Committee.

 

The Committee continues to be grateful for the feedback received and the two-way engagement with major shareholders. Given overall majority support was obtained for the Policy resolution, it is not proposed to make any further changes to the approach to remuneration that was set out in the 2022 Annual Report. The Company will, however, continue to keep the Policy under review over the coming years and welcomes ongoing dialogue with shareholders and proxy advisers.

 

 

Enquiries:

Clare Sheridan, Company Secretary +44 (0) 20 7307 9200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFZLFBXKLEBBF
Date   Source Headline
22nd Apr 202410:35 amRNSBlock listing Interim Review
8th Apr 20247:00 amRNSDirectorate Changes: Update
2nd Apr 202412:38 pmRNSTotal Voting Rights
21st Mar 20242:17 pmRNSAnnual Financial Report
19th Mar 20243:45 pmRNSAdditional Listing
5th Mar 20243:05 pmRNSDirector/PDMR Shareholding
5th Mar 20243:04 pmRNSDirector/PDMR Shareholding
5th Mar 20242:53 pmRNSDirector/PDMR Shareholding
4th Mar 20243:49 pmRNSDirector/PDMR Shareholding
4th Mar 20243:49 pmRNSDirector/PDMR Shareholding
1st Mar 20243:19 pmRNSTotal Voting Rights
22nd Feb 20247:00 amRNSRESULTS FOR THE FULL YEAR ENDED 31 DECEMBER 2023
5th Feb 20247:00 amRNSNotice of Full Year Results
1st Feb 202410:25 amRNSTotal Voting Rights
19th Jan 20244:14 pmRNSHolding(s) in Company
17th Jan 20245:11 pmRNSHolding(s) in Company
12th Jan 20243:25 pmRNSHolding(s) in Company
2nd Jan 202412:21 pmRNSTotal Voting Rights
12th Dec 20237:00 amRNSDirectorship Changes
7th Dec 20235:40 pmRNSHolding(s) in Company
6th Dec 20234:33 pmRNSHolding(s) in Company
1st Dec 202312:13 pmRNSTotal Voting Rights
23rd Nov 20237:00 amRNSDirectorship Changes
22nd Nov 20232:31 pmRNSAdditional Listing
3rd Nov 20234:15 pmRNSHolding(s) in Company
2nd Nov 20237:00 amRNSTrading Update
1st Nov 202311:14 amRNSTotal Voting Rights
26th Oct 20234:43 pmRNSHolding(s) in Company
20th Oct 20239:05 amRNSBlock listing Interim Review
10th Oct 202311:44 amRNSAdditional Listing
12th Sep 20233:12 pmRNSHolding(s) in Company
4th Sep 202312:51 pmRNSAGM Voting Update
1st Sep 20239:45 amRNSTotal Voting Rights
22nd Aug 20233:56 pmRNSAdditional Listing
10th Aug 202311:50 amRNSDirector/PDMR Shareholding
10th Aug 202311:45 amRNSDirector/PDMR Shareholding
2nd Aug 20236:30 pmRNSResults for the Half Year (HY) Ended 30 June 2023
1st Aug 202311:13 amRNSTotal Voting Rights
10th Jul 20237:00 amRNSNotice of Half Year Results
3rd Jul 202310:37 amRNSTotal Voting Rights
29th Jun 20237:00 amRNSTrading Update
14th Jun 20232:10 pmRNSAdditional Listing
14th Jun 20239:13 amRNSHolding(s) in Company
12th Jun 20233:50 pmRNSHolding(s) in Company
1st Jun 20239:16 amRNSTotal Voting Rights
31st May 20234:10 pmRNSHolding(s) in Company
10th May 202311:19 amRNSAdditional Listing
5th May 20232:38 pmRNSHolding(s) in Company
4th May 202312:44 pmRNSResult of AGM
4th May 20237:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.